Ding Yinyin, Huang Tianfeng, Ge Yali, Gao Ju, Zhang Yang
Department of Anesthesiology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
Front Med (Lausanne). 2023 Sep 7;10:1212646. doi: 10.3389/fmed.2023.1212646. eCollection 2023.
Reflux aspiration is a rare but serious complication during induction of anesthesia. The primary aim of this study is to compare the incidence of reflux and microaspiration in patients undergoing laparoscopic cholecystectomy during induction of general anesthesia using either a facemask or trans-nasal humidified rapid insufflation ventilatory exchange.
We conducted a single-center, randomized, controlled trial. Thirty patients were allocated to either a facemask or a trans-nasal humidified rapid insufflation ventilatory exchange (THRIVE) group. Pre-oxygenation for 5 min with a facemask or THRIVE, positive pressure ventilation for 2 min or THRIVE for 2 min after anesthesia induction was followed. Before endotracheal intubation, the secretion above and below the glottis was collected to measure pepsin content and analyze blood gas. The ELISA assay for supra- and subglottic human pepsin content was used to detect the presence of reflux and microaspiration. The primary outcome was the incidence of reflux and microaspiration. Secondary outcomes were apnea time, PaO before tracheal intubation, and the end-expiratory carbon dioxide partial pressure.
Patients in the THRIVE group had a significantly longer apnea time (379.55 ± 94.12 s) compared to patients in the facemask group (172.96 ± 58.87 s; < 0.001). There were no differences observed in PaO between the groups. A significant difference in gastric insufflation, reflux, and microaspiration was observed between the groups. Gastric insufflation was 6.9% in the THRIVE group vs. 28.57% kPa in the facemask group ( = 0.041); reflux was 10.34% in the THRIVE group vs. 32.14% kPa in the facemask group ( = 0.044); and microaspiration was 0% in the THRIVE group vs. 17.86% kPa in the facemask group ( = 0.023).
The application of THRIVE during induction of general anesthesia reduced the incidence of reflux and microaspiration while ensuring oxygenation and prolonged apnea time in laparoscopic cholecystectomy patients. THRIVE may be an optimal way to administer oxygen during the induction of general anesthesia in laparoscopic cholecystectomy patients.
Chinese Clinical Trial Registry, No: ChiCTR2100054086, https://www.chictr.org.cn/indexEN.html.
反流误吸是麻醉诱导期间一种罕见但严重的并发症。本研究的主要目的是比较在全身麻醉诱导期间使用面罩或经鼻湿化快速充气通气交换的腹腔镜胆囊切除术患者的反流和微误吸发生率。
我们进行了一项单中心、随机、对照试验。30例患者被分配至面罩组或经鼻湿化快速充气通气交换(THRIVE)组。采用面罩或THRIVE进行5分钟预给氧,麻醉诱导后进行2分钟正压通气或2分钟THRIVE。在气管插管前,收集声门上和声门下分泌物以测量胃蛋白酶含量并分析血气。采用酶联免疫吸附测定法检测声门上和声门下人胃蛋白酶含量,以检测反流和微误吸的存在。主要结局是反流和微误吸的发生率。次要结局是呼吸暂停时间、气管插管前的动脉血氧分压(PaO)以及呼气末二氧化碳分压。
与面罩组患者(172.96±58.87秒;P<0.001)相比,THRIVE组患者的呼吸暂停时间显著更长(379.55±94.12秒)。两组之间的动脉血氧分压未观察到差异。两组之间在胃充气、反流和微误吸方面观察到显著差异。THRIVE组的胃充气率为6.9%,而面罩组为28.57%(P=0.041);THRIVE组的反流率为10.34%,而面罩组为32.14%(P=0.044);THRIVE组的微误吸率为0%,而面罩组为17.86%(P=0.023)。
在全身麻醉诱导期间应用THRIVE可降低腹腔镜胆囊切除术患者的反流和微误吸发生率,同时确保氧合并延长呼吸暂停时间。THRIVE可能是腹腔镜胆囊切除术患者全身麻醉诱导期间给氧的最佳方式。
中国临床试验注册中心,编号:ChiCTR2100054086,https://www.chictr.org.cn/indexEN.html。